SLP (Simulations Plus) GF Value : $60.28 (As of Dec. 14, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus GF Value?

As of today (2024-12-14), Simulations Plus's share price is $30.93. Simulations Plus's GF Value is $60.28. Therefore, Simulations Plus's Price-to-GF-Value for today is 0.51. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Simulations Plus is Significantly Undervalued.

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

Simulations Plus (NAS:SLP) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Simulations Plus's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	30.93	/	60.28
	=	0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus GF Value Related Terms

Thank you for viewing the detailed overview of Simulations Plus's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Simulations Plus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

42505 Tenth Street West, Lancaster, CA, USA, 93534-7059

Website

https://www.simulations-plus.com

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Executives

Walter S Woltosz	director, 10 percent owner, officer: Chairman and CEO	42505 10TH ST. WEST, LANCASTER CA 93534
Lisa Lavange	director	42505 10TH ST., WEST, LANCASTER CA 93534
Daniel L Weiner	director	800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
John Kenneth Paglia	director	746 GRABLE PLACE, NEWBURY PARK CA 91320
Dibella John Anthony Ii	officer: Division President	42505 10TH STREET WEST, LANCASTER CA 93534
Steven Chang	officer: President, Immunetrics	42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor	officer: Chief Executive Officer	42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly	officer: President, Cognigen Division	42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell	officer: President, DILIsym Division	42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick	officer: CFO	C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Sharlene Evans	director	42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen	officer: VP of Human Resources	42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph	director	42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel	officer: CFO	42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr	director, officer: President	1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221